NCT01222676 2013-08-12Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the BladderNational Cancer Institute (NCI)Phase 2 Unknown45 enrolled